Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors

被引：30
|
作者：
Boot, J
Cases, M
Clark, BP
Findlay, J
Gallagher, PT
Hayhurst, L
Man, T
Montalbetti, C
Rathmell, RE
Rudyk, H
Walter, MW
Whatton, M
Wood, V
机构：
[1] Eli Lilly & Co, Lilly Res Ctr, Windlesham GU20 6PH, Surrey, England
[2] Evotec OAI, Abingdon OX14 4SD, Oxon, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 03期
关键词：
monoamine reuptake inhibitors; selective norepinephrine reuptake inhibitor; dual reuptake inhibitor; SAR; serotonin; norepinephrine;
D O I：
10.1016/j.bmcl.2004.11.025
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Novel arylthiomethyl morpholines are potent selective norepinephrine reuptake inhibitors (NERIs) and dual serotonin/ norepinephrine reuptake inhibitors (SRI/NERIs). The target compounds were prepared using a stereochemically versatile synthesis featuring an aldol condensation as the key step. One enantiomer of the 2-methoxy-substituted analogue was found to be a potent and selective norepinephrine reuptake inhibitor, whereas the opposite enantiomer was a potent dual serotonin/norepinephrine reuptake inhibitor. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：699 / 703
页数：5
相关论文
共 50 条
  • [31] Selective serotonin-norepinephrine reuptake inhibitors-induced Takotsubo cardiomyopathy
    Vasudev, Rahul
    Rampal, Upamanyu
    Patel, Hiten
    Patel, Kunal
    Bikkina, Mahesh
    Shamoon, Fayez
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2016, 8 (07) : 312 - 315
  • [32] EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND SEROTONIN NOREPINEPHRINE REUPTAKE INHIBITORS ON BONE MINERAL DENSITY IN EGYPTIAN PATIENTS WITH PRIMARY FIBROMYALGIA
    Gazar, Y. Hussein
    Hamoud, H. Salah
    Ghait, M.
    Harb, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S197 - S198
  • [33] EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND SEROTONIN NOREPINEPHRINE REUPTAKE INHIBITORS ON BONE MINERAL DENSITY IN EGYPTION PATIENTS WITH PRIMARY FIBROMYALGIA
    Gazar, Y.
    Hamoud, Hesham Salah
    Ghait, Mohammed Magdy
    Harb, Mohammed
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1768 - 1769
  • [34] Pharmacophore Identidification and Comparison of Serotonin/Norepinephrine Reuptake Inhibitors
    Qin Fang
    Guo Yanshen
    Wen Hui
    Yang Guangzhong
    ACTA CHIMICA SINICA, 2009, 67 (19) : 2258 - 2268
  • [35] Suicidality during treatment with serotonin and norepinephrine reuptake inhibitors
    Da Fonseca Pinto, I.
    Elias de Sousa, A.
    Vieira-Coelho, M. A.
    EUROPEAN PSYCHIATRY, 2024, 67 : S182 - S182
  • [36] Treatment of Comorbid Pain with Serotonin Norepinephrine Reuptake Inhibitors
    Briley, Mike
    Moret, Chantal
    CNS SPECTRUMS, 2008, 13 (07) : 22 - 26
  • [37] Serotonin and norepinephrine reuptake inhibitors (SNRIs): Venlafaxine and duloxetine
    Lee, SI
    Keltner, NL
    PERSPECTIVES IN PSYCHIATRIC CARE, 2006, 42 (02) : 144 - 148
  • [38] N-alkyl-N-arylmethylpiperidin-4-amines:: Novel dual inhibitors of serotonin and norepinephrine reuptake
    Boot, JR
    Boulet, SL
    Clark, BP
    Cases-Thomas, MJ
    Delhaye, L
    Diker, K
    Fairhurst, J
    Findlay, J
    Gallagher, PT
    Gilmore, J
    Harris, JR
    Masters, JJ
    Mitchell, SN
    Naik, M
    Simmonds, RG
    Smith, SM
    Richards, SJ
    Timms, GH
    Whatton, MA
    Wolfe, CN
    Wood, VA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (10) : 2714 - 2718
  • [39] Treating depression with selective norepinephrine reuptake inhibitors
    Blier, P
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2006, 31 (04): : 288 - 288
  • [40] Treatment of psychodermatoses with serotonin-norepinephrine reuptake inhibitors
    Yashar, SS
    Moiin, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P9 - P9
12345